Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Zameel Cader talks to the Oxford Mail about his research

Headache will affect most people during their life and is one of the commonest reasons to see a doctor. Migraine costs the UK economy over £3bn a year. For many people there are effective treatments, but for a good number of people the existing treatments don’t work.

Dr Zameel Cader of the Nuffield Department of Clinical Neurosciences helped to set up the Oxford Headache Centre to unite researchers and clinicians with the common purpose of improving the lives of headache sufferers.

Read more in the Oxford Mail.


Similar stories

John Jacob wins clinical academic research partnership for brain cancer project

The Medical Research Council awarded Dr John Jacob upwards of £200,000 to fund a project on brain cancer modelling.

New consortium to uncover mechanisms of neuropathic pain

Professor David Bennett is leading a new national research consortium to investigate neuropathic pain.

Capturing immune cells that colonise the brain to prevent disease progression in multiple sclerosis

Researchers have revealed a disease-causing population of immune cells, which travel to the brain in patients with multiple sclerosis. They demonstrate how to trap these cells in the blood, which means they can be targeted to prevent disease progression.

Two neurologists awarded MRC Senior Clinical Fellowships

Two of our Associate Professors, Sarosh Irani and George Tofaris, have been awarded MRC Senior Clinical Fellowships.

Developing diagnostics for COVID-19

Associate Professor Sarosh Irani, who heads up our Autoimmune Neurology Group, has been funded by Mologic to help develop diagnostics for COVID-19.